This is the first time a public company in Catalonia has manufactured advanced cell therapy drugs, which allow for the regeneration of injured or degenerated tissues.
According to 'Catalonia Life Sciences Report' presented by Ernst&Young and Biocat under the framework of the BIO International Convention in Boston (USA).
Experts from Catalonia and Valencia forecast that the future will rely on expertise, on researchers’ ability to address real needs and on public/private collaboration systems to compete with countries like China.
